Glutaredoxin mediates Akt and eNOS activation by flow in a glutathione reductase-dependent manner

Arterioscler Thromb Vasc Biol. 2007 Jun;27(6):1283-8. doi: 10.1161/ATVBAHA.107.144659. Epub 2007 Apr 12.

Abstract

Objective: The glutathione (GSH)/glutaredoxin (Grx) system regulates activities of many redox sensitive enzymes. This system has been shown to protect cells from hydrogen peroxide-induced apoptosis by regulating the redox state of Akt. Grx can be regulated by redox state; the oxidized Grx is selectively recycled to the reduced form by GSH. Flow can maintain endothelial cells in a reduced state by activating glutathione reductase (GR) and increasing the GSH/GSSG ratio. Because steady laminar flow exerts an antioxidant effect, we hypothesized that Grx mediates flow induced Akt and eNOS phosphorylation in a GR dependent manner.

Methods and results: Exposure of endothelial cells (ECs) to physiological steady laminar flow (shear stress=12 dyn/cm2) for 5 minutes significantly increased Grx activity (1.9+/-0.2-fold), and also increased Akt and eNOS phosphorylation. Overexpression of GFP-GR in ECs significantly increased Grx activity by 1.6+/-0.1-fold. Pretreatment with the GR inhibitor 1,3-bis[2-chloroethyl]-1-nitrosourea (BCNU) for 30 minutes dramatically reduced Grx activity and inhibited the increase in Akt and eNOS phosphorylation induced by flow. Overexpression of wild-type Grx in ECs increased both Akt and eNOS phosphorylation. In contrast, a mutated Grx (C22S/C25S), which lacks thioltransferase activity, had no effect. Therefore, flow-induced Akt and eNOS phosphorylation depend on Grx thioltransferase activity. Downregulation of Grx by small interfering RNA decreased flow induced Akt and eNOS phosphorylation.

Conclusions: These data suggest that Grx is an important mediator for flow-induced Akt and eNOS activation, and Grx activity depends on GR-mediated changes in EC redox state.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Carmustine / pharmacology
  • Cattle
  • Cells, Cultured
  • Endothelial Cells / drug effects
  • Endothelial Cells / metabolism*
  • Environment, Controlled*
  • Enzyme Activation
  • Enzyme Inhibitors / pharmacology
  • Glutaredoxins
  • Glutathione / metabolism*
  • Glutathione Reductase / antagonists & inhibitors
  • Glutathione Reductase / genetics
  • Glutathione Reductase / metabolism*
  • Humans
  • Mutation
  • Nitric Oxide Synthase Type III / metabolism*
  • Oxidation-Reduction
  • Oxidoreductases / genetics
  • Oxidoreductases / metabolism*
  • Phosphorylation
  • Proto-Oncogene Proteins c-akt / metabolism*
  • RNA Interference
  • RNA, Small Interfering / genetics
  • RNA, Small Interfering / metabolism
  • Signal Transduction*
  • Stress, Mechanical
  • Transfection

Substances

  • Enzyme Inhibitors
  • GLRX protein, human
  • Glutaredoxins
  • RNA, Small Interfering
  • Oxidoreductases
  • Nitric Oxide Synthase Type III
  • Glutathione Reductase
  • Proto-Oncogene Proteins c-akt
  • Glutathione
  • Carmustine